Selected research
Industry Research
Astringent Industry Research Report 2026
Market perspective
The global Astringent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Astringent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Astringent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Astringent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Astringent include Pfizer, Z-Medica, Vascular Solutions, The Medicines Company, Marine Polymer Technologies, Integra LifeSciences, Gelita Medical, Ethicon and Equimedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Astringent market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Astringent Market by Company
Pfizer
Z-Medica
Vascular Solutions
The Medicines Company
Marine Polymer Technologies
Integra LifeSciences
Gelita Medical
Ethicon
Equimedical
CryoLife
C. R. Bard
Biom’Up SAS
BioCer Entwicklungs
Baxter International
B Braun Melsungen
Anika Therapeutics
Advanced Medical Solutions
Astringent Segment by Type
Combination Astringent
Oxidized Regenerated Cellulose Based Astringent
Thrombin-based Astringent
Gelatin-based Astringent
Collagen-based Astringent
Astringent Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Astringent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Astringent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Astringent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Astringent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Astringent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Astringent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Astringent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Combination Astringent
- Oxidized Regenerated Cellulose Based Astringent
- Thrombin-based Astringent
- Gelatin-based Astringent
- Collagen-based Astringent
Applications
- Hospitals
- Surgical Centers
- Nursing Homes
Companies covered
- Pfizer
- Z-Medica
- Vascular Solutions
- The Medicines Company
- Marine Polymer Technologies
- Integra LifeSciences
- Gelita Medical
- Ethicon
- Equimedical
- CryoLife
- C. R. Bard
- Biom’Up SAS
- BioCer Entwicklungs
- Baxter International
- B Braun Melsungen
- Anika Therapeutics
- Advanced Medical Solutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Astringent Market Size (2021-2032)
- 2.2.2 Global Astringent Sales (2021-2032)
- 2.2.3 Global Astringent Market Average Price (2021-2032)
- 2.3 Astringent by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Combination Astringent
- 2.3.3 Oxidized Regenerated Cellulose Based Astringent
- 2.3.4 Thrombin-based Astringent
- 2.3.5 Gelatin-based Astringent
- 2.3.6 Collagen-based Astringent
- 2.4 Astringent by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Surgical Centers
- 2.4.4 Nursing Homes
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Astringent Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Astringent Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Astringent Revenue of Manufacturers (2021-2026)
- 3.4 Global Astringent Average Price by Manufacturers (2021-2026)
- 3.5 Global Astringent Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Astringent, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Astringent, Product Type & Application
- 3.8 Global Manufacturers of Astringent, Established Date
- 3.9 Global Astringent Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Astringent Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Z-Medica
- 4.2.1 Z-Medica Company Information
- 4.2.2 Z-Medica Business Overview
- 4.2.3 Z-Medica Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Z-Medica Astringent Product Portfolio
- 4.2.5 Z-Medica Recent Developments
- 4.3 Vascular Solutions
- 4.3.1 Vascular Solutions Company Information
- 4.3.2 Vascular Solutions Business Overview
- 4.3.3 Vascular Solutions Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vascular Solutions Astringent Product Portfolio
- 4.3.5 Vascular Solutions Recent Developments
- 4.4 The Medicines Company
- 4.4.1 The Medicines Company Company Information
- 4.4.2 The Medicines Company Business Overview
- 4.4.3 The Medicines Company Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 The Medicines Company Astringent Product Portfolio
- 4.4.5 The Medicines Company Recent Developments
- 4.5 Marine Polymer Technologies
- 4.5.1 Marine Polymer Technologies Company Information
- 4.5.2 Marine Polymer Technologies Business Overview
- 4.5.3 Marine Polymer Technologies Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Marine Polymer Technologies Astringent Product Portfolio
- 4.5.5 Marine Polymer Technologies Recent Developments
- 4.6 Integra LifeSciences
- 4.6.1 Integra LifeSciences Company Information
- 4.6.2 Integra LifeSciences Business Overview
- 4.6.3 Integra LifeSciences Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Integra LifeSciences Astringent Product Portfolio
- 4.6.5 Integra LifeSciences Recent Developments
- 4.7 Gelita Medical
- 4.7.1 Gelita Medical Company Information
- 4.7.2 Gelita Medical Business Overview
- 4.7.3 Gelita Medical Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gelita Medical Astringent Product Portfolio
- 4.7.5 Gelita Medical Recent Developments
- 4.8 Ethicon
- 4.8.1 Ethicon Company Information
- 4.8.2 Ethicon Business Overview
- 4.8.3 Ethicon Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ethicon Astringent Product Portfolio
- 4.8.5 Ethicon Recent Developments
- 4.9 Equimedical
- 4.9.1 Equimedical Company Information
- 4.9.2 Equimedical Business Overview
- 4.9.3 Equimedical Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Equimedical Astringent Product Portfolio
- 4.9.5 Equimedical Recent Developments
- 4.10 CryoLife
- 4.10.1 CryoLife Company Information
- 4.10.2 CryoLife Business Overview
- 4.10.3 CryoLife Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CryoLife Astringent Product Portfolio
- 4.10.5 CryoLife Recent Developments
- 4.11 C. R. Bard
- 4.11.1 C. R. Bard Company Information
- 4.11.2 C. R. Bard Business Overview
- 4.11.3 C. R. Bard Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 C. R. Bard Astringent Product Portfolio
- 4.11.5 C. R. Bard Recent Developments
- 4.12 Biom’Up SAS
- 4.12.1 Biom’Up SAS Company Information
- 4.12.2 Biom’Up SAS Business Overview
- 4.12.3 Biom’Up SAS Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biom’Up SAS Astringent Product Portfolio
- 4.12.5 Biom’Up SAS Recent Developments
- 4.13 BioCer Entwicklungs
- 4.13.1 BioCer Entwicklungs Company Information
- 4.13.2 BioCer Entwicklungs Business Overview
- 4.13.3 BioCer Entwicklungs Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 BioCer Entwicklungs Astringent Product Portfolio
- 4.13.5 BioCer Entwicklungs Recent Developments
- 4.14 Baxter International
- 4.14.1 Baxter International Company Information
- 4.14.2 Baxter International Business Overview
- 4.14.3 Baxter International Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Baxter International Astringent Product Portfolio
- 4.14.5 Baxter International Recent Developments
- 4.15 B Braun Melsungen
- 4.15.1 B Braun Melsungen Company Information
- 4.15.2 B Braun Melsungen Business Overview
- 4.15.3 B Braun Melsungen Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 B Braun Melsungen Astringent Product Portfolio
- 4.15.5 B Braun Melsungen Recent Developments
- 4.16 Anika Therapeutics
- 4.16.1 Anika Therapeutics Company Information
- 4.16.2 Anika Therapeutics Business Overview
- 4.16.3 Anika Therapeutics Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Anika Therapeutics Astringent Product Portfolio
- 4.16.5 Anika Therapeutics Recent Developments
- 4.17 Advanced Medical Solutions
- 4.17.1 Advanced Medical Solutions Company Information
- 4.17.2 Advanced Medical Solutions Business Overview
- 4.17.3 Advanced Medical Solutions Astringent Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Advanced Medical Solutions Astringent Product Portfolio
- 4.17.5 Advanced Medical Solutions Recent Developments
5 Global Astringent Market Scenario by Region
- 5.1 Global Astringent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Astringent Sales by Region: 2021-2032
- 5.2.1 Global Astringent Sales by Region: 2021-2026
- 5.2.2 Global Astringent Sales by Region: 2027-2032
- 5.3 Global Astringent Revenue by Region: 2021-2032
- 5.3.1 Global Astringent Revenue by Region: 2021-2026
- 5.3.2 Global Astringent Revenue by Region: 2027-2032
- 5.4 North America Astringent Market Facts & Figures by Country
- 5.4.1 North America Astringent Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Astringent Sales by Country (2021-2032)
- 5.4.3 North America Astringent Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Astringent Market Facts & Figures by Country
- 5.5.1 Europe Astringent Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Astringent Sales by Country (2021-2032)
- 5.5.3 Europe Astringent Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Astringent Market Facts & Figures by Country
- 5.6.1 Asia Pacific Astringent Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Astringent Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Astringent Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Astringent Market Facts & Figures by Country
- 5.7.1 South America Astringent Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Astringent Sales by Country (2021-2032)
- 5.7.3 South America Astringent Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Astringent Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Astringent Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Astringent Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Astringent Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Astringent Sales by Type (2021-2032)
- 6.1.1 Global Astringent Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Astringent Sales Market Share by Type (2021-2032)
- 6.2 Global Astringent Revenue by Type (2021-2032)
- 6.2.1 Global Astringent Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Astringent Revenue Market Share by Type (2021-2032)
- 6.3 Global Astringent Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Astringent Sales by Application (2021-2032)
- 7.1.1 Global Astringent Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Astringent Sales Market Share by Application (2021-2032)
- 7.2 Global Astringent Revenue by Application (2021-2032)
- 7.2.1 Global Astringent Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Astringent Revenue Market Share by Application (2021-2032)
- 7.3 Global Astringent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Astringent Value Chain Analysis
- 8.1.1 Astringent Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Astringent Production Mode & Process
- 8.2 Astringent Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Astringent Distributors
- 8.2.3 Astringent Customers
9 Global Astringent Analyzing Market Dynamics
- 9.1 Astringent Industry Trends
- 9.2 Astringent Industry Drivers
- 9.3 Astringent Industry Opportunities and Challenges
- 9.4 Astringent Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst